Novozymes A/S (NVZMY) Q4 2025 Earnings Call Transcript
2026-02-25 07:31:36 ET
Novozymes A/S (NVZMY) Q4 2025 Earnings Call February 25, 2026 3:00 AM EST
Company Participants
Tobias Björklund - Head of Investor Relations
Ester Baiget - President & CEO
Rainer Lehmann - Executive VP & CFO
Henrik Nielsen - EVP of Human Health Biosolutions and Strategy & Integration
Claus Fuglsang - Chief Scientific Officer
Andrew Taylor - Executive Vice President of Food & Beverage Biosolutions
Tina Fanø - Executive Vice President of Planetary Health Biosolutions
...
Read the full article on Seeking Alpha
For further details see:
Novozymes A/S (NVZMY) Q4 2025 Earnings Call TranscriptNASDAQ: NVZMF
NVZMF Trading
-2.1% G/L:
$56.14 Last:
144 Volume:
$57.342 Open:



